About the conference

TREAT-NMD is an international network currently funded by the EU that aims to advance diagnosis, care and therapy development for the benefit of patients and families. It links scientists and healthcare professionals, the pharmaceutical industry, regulators and patient groups all over the world.

This international conference provides a unique focus on the challenges facing therapy development for inherited neuromuscular diseases.

PROGENA FOUNDATION, local host and co-organiser of this conference, is a Swiss patient organisation raising funds for the research against rare genetic diseases and providing support for families.

The conference sessions will look at the range of issues involved in therapy development in inherited neuromuscular diseases as well as discussing the latest research developments in this area.

Download a PDF of the conference programme.